Booster Dose of COVID 19 and Ethical Issues
DOI:
https://doi.org/10.53685/jshmdc.v2i2.82Abstract
COVID 19 is a recent and global pandemic. Preventive medicine is not very popular in Pakistan. With the limited resources, an average Pakistani would spend on a medical treatment rather than on a preventive drug. In Pakistan, booster shots are recently made available only to those who can pay for the cost of the vaccine. A Utilitarian approach has been adopted at various levels since the pandemic emerged by health care organizations and the government. The purpose was to maximize the benefits and minimize the risk of harm. It is the need of the hour to think about health equity and justice in a pluralistic way and refrain from initiating booster shots for elite of a resource-poor country. This pandemic will never end if a maximum number of people are not vaccinated in each country. This is only possible if there is an equitable distribution of vaccines.
References
Statistics and Research: Coronavirus (COVID-19) Vaccinations. Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/covid-vaccinations.
Abid K, Bari YA, Younas M, Tahir Javaid S, Imran A. Progress of COVID-19 Epidemic in Pakistan. Asia Pac J Public Health. 2020; 32(4): 154-156 DOI: https://doi.org/10.1177/1010539520927259
World Health Organization. Vaccine equity. Retrieved from: https://www.who.int/campaigns/vaccine- equity.
The Lancet Infectious Diseases. COVID-19 vaccine equity and booster doses. Lancet Infect Dis. 2021; 21(9): 1193. DOI: https://doi.org/10.1016/S1473-3099(21)00486-2
Jecker NS, Lederman Z. Three for me and none for you? An ethical argument for delaying COVID-19 boosters. J Med Ethics. 2021: medethics-2021-107824. DOI: https://doi.org/10.1136/medethics-2021-107824
Schaefer GO, Leland RJ, Emanuel EJ. Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations. JAMA. 2021; 326(10): 903-904 DOI: https://doi.org/10.1001/jama.2021.13226
Bernal J.L., Andrews N., Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021; 385(7): 585-594. DOI: https://doi.org/10.1056/NEJMoa2108891
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Adeela Shahid
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
Non Commercial — You may not use the material for commercial purposes.
-
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.